hydroxyurea has been researched along with Myocardial Infarction in 15 studies
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
Excerpt | Relevance | Reference |
---|---|---|
"BACKGROUND This study aimed to decrease leukocytes counts by hydroxyurea (Hu) in an acute myocardial infarction (AMI) rat model and examine its effect on the inflammatory response of myocardial infarction and cardiac functions." | 7.81 | Reduction of Leukocyte Counts by Hydroxyurea Improves Cardiac Function in Rats with Acute Myocardial Infarction. ( Pan, L; Yan, S; Yao, Y; Zhu, G; Zhu, W, 2015) |
"We describe a 28-year-old man treated with hydroxyurea for sickle cell anemia, who was admitted to the University Hospital with an acute myocardial infarction." | 7.73 | Acute myocardial infarction in sickle cell disease: a possible complication of hydroxyurea treatment. ( Costa, FF; de Souza, RA; Fattori, A; Saad, ST, 2005) |
"BACKGROUND This study aimed to decrease leukocytes counts by hydroxyurea (Hu) in an acute myocardial infarction (AMI) rat model and examine its effect on the inflammatory response of myocardial infarction and cardiac functions." | 3.81 | Reduction of Leukocyte Counts by Hydroxyurea Improves Cardiac Function in Rats with Acute Myocardial Infarction. ( Pan, L; Yan, S; Yao, Y; Zhu, G; Zhu, W, 2015) |
"We describe a 28-year-old man treated with hydroxyurea for sickle cell anemia, who was admitted to the University Hospital with an acute myocardial infarction." | 3.73 | Acute myocardial infarction in sickle cell disease: a possible complication of hydroxyurea treatment. ( Costa, FF; de Souza, RA; Fattori, A; Saad, ST, 2005) |
"Venous thrombosis is more frequent in PV than in ET; superficial or deep venous thromboses are seen." | 2.41 | [What vascular events suggest a myeloproliferative disorder?]. ( Caulier-Leleu, MT; Hachulla, E; Pasturel-Michon, U; Rose, C; Trillot, N, 2000) |
"Previous thrombosis is an established risk factor for rethrombosis in patients with ET." | 1.38 | Cerebral infarct in a patient with a history of systemic arterial and venous thrombosis from essential thrombocythemia. ( Cho, KH; Kim, KT; Sohn, SI, 2012) |
"Only one report of recurrence of myocardial infarction has been previously described." | 1.31 | Essential thrombocythemia and recurrent myocardial infarction. ( Akarsu, E; Bozkurt, E; Gündogdu, M; Kaya, H; Tekin, SB, 2000) |
"Hydroxyurea was given to patients with ET with a positive history for major vascular complications or with an extreme thrombocytosis." | 1.30 | Acute coronary disease in essential thrombocythemia and polycythemia vera. ( Girolami, A; Randi, ML; Rinaldi, V; Rossi, C; Zerbinati, P, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.67) | 18.7374 |
1990's | 1 (6.67) | 18.2507 |
2000's | 9 (60.00) | 29.6817 |
2010's | 4 (26.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhu, G | 1 |
Yao, Y | 1 |
Pan, L | 1 |
Zhu, W | 1 |
Yan, S | 1 |
Abueid, L | 1 |
Uslu, Ü | 1 |
Cumbul, A | 1 |
Velioğlu Öğünç, A | 1 |
Ercan, F | 1 |
Alican, İ | 1 |
Bildirici, U | 1 |
Celikyurt, U | 1 |
Ural, E | 1 |
Zhang, Z | 1 |
Wan, X | 1 |
Liu, Y | 1 |
Lin, X | 1 |
Ni, Z | 1 |
Yang, X | 1 |
Zhang, L | 1 |
Kim, KT | 1 |
Sohn, SI | 1 |
Cho, KH | 1 |
Gabriel, L | 1 |
de Meester, A | 1 |
Fattori, A | 1 |
de Souza, RA | 1 |
Saad, ST | 1 |
Costa, FF | 1 |
Giordano, PC | 1 |
Kelly, SV | 1 |
Burke, RF | 1 |
Lee, KS | 1 |
Torloni, AS | 1 |
Lee, RW | 1 |
Northfelt, D | 1 |
Fonseca, R | 1 |
Tekin, M | 1 |
Gökaslan, S | 1 |
Diker, E | 1 |
Aydoğdu, S | 1 |
Mullane, KM | 1 |
Read, N | 1 |
Salmon, JA | 1 |
Moncada, S | 1 |
Rossi, C | 1 |
Randi, ML | 1 |
Zerbinati, P | 1 |
Rinaldi, V | 1 |
Girolami, A | 1 |
Kaya, H | 1 |
Gündogdu, M | 1 |
Tekin, SB | 1 |
Akarsu, E | 1 |
Bozkurt, E | 1 |
Hachulla, E | 1 |
Rose, C | 1 |
Trillot, N | 1 |
Caulier-Leleu, MT | 1 |
Pasturel-Michon, U | 1 |
Ghotekar, LH | 1 |
Dutta, TK | 1 |
Kumarasamy, V | 1 |
1 review available for hydroxyurea and Myocardial Infarction
Article | Year |
---|---|
[What vascular events suggest a myeloproliferative disorder?].
Topics: Adult; Aged; Alkylating Agents; Arterial Occlusive Diseases; Cross-Sectional Studies; Erythromelalgi | 2000 |
14 other studies available for hydroxyurea and Myocardial Infarction
Article | Year |
---|---|
Reduction of Leukocyte Counts by Hydroxyurea Improves Cardiac Function in Rats with Acute Myocardial Infarction.
Topics: Animals; Echocardiography; Electrocardiography; Heart Function Tests; Hydroxyurea; Leukocyte Count; | 2015 |
Inhibition of 5-lipoxygenase by zileuton in a rat model of myocardial infarction.
Topics: Animals; Arachidonate 5-Lipoxygenase; Disease Models, Animal; Hydroxyurea; Leukotriene Antagonists; | 2017 |
Essential thrombocythemia: a case of acute ST-segment elevation myocardial infarction in a young female.
Topics: Adult; Age Factors; Antisickling Agents; Aspirin; Clopidogrel; Coronary Angiography; Female; Fibrino | 2009 |
Non-ST-segment elevation myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor: a case report.
Topics: Electrocardiography; Enzyme Inhibitors; Humans; Hydroxyurea; Male; Middle Aged; Myocardial Infarctio | 2011 |
Cerebral infarct in a patient with a history of systemic arterial and venous thrombosis from essential thrombocythemia.
Topics: Arterial Occlusive Diseases; Biopsy; Bone Marrow Examination; Cerebral Angiography; Cerebral Infarct | 2012 |
Myocardial infarction and primary thrombocytosis in a young man.
Topics: Adult; Antineoplastic Agents; Coronary Angiography; Electrocardiography; Fibrinolytic Agents; Humans | 2003 |
Acute myocardial infarction in sickle cell disease: a possible complication of hydroxyurea treatment.
Topics: Adult; Anemia, Sickle Cell; Antisickling Agents; Blood Viscosity; Hematocrit; Hemoglobins; Humans; H | 2005 |
Brief comment on the case report by Fattori et al. 2005 (5) 589-590.
Topics: Adult; Anemia, Sickle Cell; Biopolymers; Erythrocyte Aggregation; Erythrocyte Indices; Hemoglobin, S | 2005 |
Acute myocardial infarction: an unusual presentation of essential thrombocytosis in a 17-year-old man.
Topics: Adolescent; Female; Humans; Hydroxyurea; Myocardial Infarction; Nucleic Acid Synthesis Inhibitors; P | 2008 |
[Development of acute coronary syndrome in three patients with essential thrombocythemia or polycythemia vera].
Topics: Adult; Anticoagulants; Antisickling Agents; Aspirin; Coronary Angiography; Diagnosis, Differential; | 2008 |
Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-a | 1984 |
Acute coronary disease in essential thrombocythemia and polycythemia vera.
Topics: Adult; Aged; Aging; Antisickling Agents; Aspirin; Female; Follow-Up Studies; Humans; Hydroxyurea; Ma | 1998 |
Essential thrombocythemia and recurrent myocardial infarction.
Topics: Angina, Unstable; Female; Humans; Hydroxyurea; Middle Aged; Myocardial Infarction; Platelet Count; R | 2000 |
Essential thrombocythemia--a cause of myocardial infarction in a young male.
Topics: Adult; Blood Chemical Analysis; Cardiotonic Agents; Electrocardiography; Follow-Up Studies; Heparin; | 2001 |